KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $13.5 billion.

  • Teva Pharmaceutical Industries' Total Current Liabilities rose 515.79% to $13.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.5 billion, marking a year-over-year increase of 515.79%. This contributed to the annual value of $13.5 billion for FY2025, which is 515.79% up from last year.
  • Teva Pharmaceutical Industries' Total Current Liabilities amounted to $13.5 billion in Q4 2025, which was up 515.79% from $11.5 billion recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Total Current Liabilities ranged from a high of $13.8 billion in Q3 2024 and a low of $10.4 billion during Q1 2023
  • Over the past 5 years, Teva Pharmaceutical Industries' median Total Current Liabilities value was $11.8 billion (recorded in 2021), while the average stood at $12.0 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Total Current Liabilities skyrocketed by 3247.53% in 2024 and then tumbled by 1910.53% in 2025.
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Total Current Liabilities stood at $11.0 billion in 2021, then rose by 4.01% to $11.5 billion in 2022, then rose by 6.78% to $12.2 billion in 2023, then increased by 4.48% to $12.8 billion in 2024, then increased by 5.16% to $13.5 billion in 2025.
  • Its Total Current Liabilities was $13.5 billion in Q4 2025, compared to $11.5 billion in Q3 2025 and $11.9 billion in Q2 2025.